Dec. 22, 2014 - Amarantus anticipates reporting fi
Post# of 30025
Posted On: 12/24/2014 11:27:43 AM
Dec. 22, 2014 - Amarantus anticipates reporting final top-line data of its LP-002 clinical study to assess LymPro's predictive value in diagnosing mild to severe Alzheimer's disease patients by the end of 2014 .
4M shares changed hands so far this morning. Those that have sold may have forgotten there is more news within the next seven days.
http://ir.amarantus.com/company-news/detail/1...cal-trials
4M shares changed hands so far this morning. Those that have sold may have forgotten there is more news within the next seven days.
http://ir.amarantus.com/company-news/detail/1...cal-trials
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼